The estimated Net Worth of Amerique Du Nord S.N.C. San... is at least $18.1 Miliarda dollars as of 13 October 2010. Amerique San owns over 1,017,401 units of Regeneron Pharmaceuticals stock worth over $18,054,261,002 and over the last 14 years Amerique sold REGN stock worth over $0.
Amerique has made over 1 trades of the Regeneron Pharmaceuticals stock since 2010, according to the Form 4 filled with the SEC. Most recently Amerique bought 1,017,401 units of REGN stock worth $28,487,228 on 13 October 2010.
The largest trade Amerique's ever made was buying 1,017,401 units of Regeneron Pharmaceuticals stock on 13 October 2010 worth over $28,487,228. On average, Amerique trades about 1,017,401 units every 0 days since 2010. As of 13 October 2010 Amerique still owns at least 15,816,953 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Amerique San stock trades at the bottom of the page.
Amerique's mailing address filed with the SEC is 174, AVENUE DE FRANCE174, AVENUE DE FRANCE, , PARISPARIS, I0I0, 7501375013.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis a Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: